Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03066661 |
|---|---|
| Brief Title: | Expanded Access to Entrectinib for Cancers With NTRK1/2/3, ROS1, or ALK Gene Fusions |
| First Submitted : | February 23, 2017 |
| First Submitted that Met QC Criteria : | February 23, 2017 |
| First Posted : | February 28, 2017 |
| Last Update Submitted that Met QC Criteria : | April 24, 2019 |
| Last Update Posted : | April 26, 2019 |